Treatments

Stromal Vascular Fraction Therapy

Stromal Vascular Fraction Therapy ยท Z51.89

SVF therapy: adipose-derived cell preparation, mechanism of action, clinical applications in regenerative medicine, current evidence, and comparison with other cell therapies.

2026-03-28

At a Glance

SVF therapy: adipose-derived cell preparation, mechanism of action, clinical applications in regenerative medicine, current evidence, and comparison with other cell therapies.

Definition and Overview

Stromal vascular fraction (SVF) is a heterogeneous cell mixture obtained by processing adipose tissue through enzymatic digestion (collagenase treatment) or mechanical dissociation [2]. SVF contains the following cell populations:

  • Adipose-derived mesenchymal stem cells (AD-MSCs)
  • Endothelial progenitor cells
  • Hematopoietic progenitor cells
  • Tissue macrophages and immune cells
  • Pericytes

Studies have demonstrated that adipose tissue contains approximately 500 to 2,000 times more mesenchymal stem cells than bone marrow, offering the advantage of obtaining an abundant stem cell source through minimally invasive methods [2].

Mechanism of Action

Anti-Inflammatory and Immunomodulatory Effects

AD-MSCs secrete anti-inflammatory cytokines including interleukin-10 (IL-10) and TGF-beta, while suppressing pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6). Their ability to modulate T cell and natural killer (NK) cell activity to attenuate autoimmune responses is under active investigation [1].

Promotion of Angiogenesis

Through endothelial progenitor cells and secretion of vascular endothelial growth factor (VEGF), SVF promotes angiogenesis at injury sites. Improved blood flow contributes to tissue regeneration and recovery of painful areas.

Neural Regeneration Support

AD-MSCs secrete neurotrophic factors (BDNF, NGF, GDNF) to support a neural regenerative environment. Preclinical studies have reported contributions to neural function recovery in models of small fiber neuropathy and peripheral nerve injury.

Clinical Applications

Musculoskeletal

Clinical studies are underway for degenerative osteoarthritis (knee, hip), rotator cuff injuries, and spinal disc degeneration. Small-scale studies have reported pain and functional improvement following autologous SVF intra-articular injection [3].

Chronic Pain

Research on the neural regenerative and anti-inflammatory effects of SVF is ongoing for refractory chronic pain conditions including fibromyalgia, complex regional pain syndrome (CRPS), and small fiber neuropathy.

Autonomic Nervous System Dysfunction

The potential for autonomic recovery through the anti-inflammatory and neuroregenerative effects of SVF is being explored in chronic symptoms associated with autonomic dysfunction. However, clinical evidence in this field remains in its early stages.

Skin Regeneration and Aesthetics

Studies on delayed wound healing, scarring, and facial aging have reported skin regenerative effects when SVF is used in combination with PRP [4].

Procedure Steps

1. Fat harvesting: 20 to 100 mL of adipose tissue is harvested via small incision under local anesthesia from the abdomen or thigh
2. SVF isolation: Cells are separated by enzymatic (collagenase) processing or mechanical methods, then concentrated by centrifugation
3. Injection: Same-day injection into the target site (intra-articular, intravenous, perineural, etc.)
4. Recovery: Typically performed as an outpatient procedure; 24 to 48 hours of rest is advised at the harvest site

Safety and Evidence

Since autologous cells are used, there is no risk of immune rejection. A meta-analysis of mesenchymal stem cell clinical studies (2,696 patients) confirmed overall safety [5]. Common adverse effects include procedural site pain, swelling, and bruising.

For most indications, the body of evidence consists largely of small-scale or preclinical studies, and standardized evidence accumulation through large-scale randomized controlled trials is ongoing [2].

Frequently Asked Questions

PRP (platelet-rich plasma) is a growth factor concentrate extracted from blood, primarily used for tissue regeneration and inflammation reduction. SVF is a stem cell-containing cell mixture extracted from adipose tissue, possessing broader regenerative potential with a more complex extraction process. The two therapies may also be used in combination.

A small volume of adipose tissue is harvested from the abdomen or thigh (via lipoaspiration or small incision), after which SVF is isolated through enzymatic processing or mechanical methods and injected into the target site (intra-articular, intravenous, perineural, etc.) on the same day. The entire procedure is typically completed within several hours.

Since autologous cells are used, there is no risk of immune rejection, and a meta-analysis of mesenchymal stem cell clinical studies has confirmed overall safety [5]. However, procedure-related complications such as infection, bleeding, and fat embolism are possible, so the procedure should be performed at a specialized medical facility.

Clinical studies are currently underway for degenerative osteoarthritis, chronic pain syndromes, autoimmune diseases, post-nerve injury regeneration support, and autonomic nervous system dysfunction. It should be noted that for many indications, results from large-scale randomized controlled trials (RCTs) are still being accumulated [2].

Individual variation exists, and tissue regeneration and anti-inflammatory effects develop gradually over several weeks to months. Some patients report symptom improvement beginning 2 to 4 weeks after the procedure. The duration of effects and treatment response also vary depending on the patient's condition, disease severity, and procedural technique.

References

  1. [1] Caplan AI, Correa D (2011). "The MSC: an injury drugstore." Cell Stem Cell, 9: 11-15. DOI PubMed
  2. [2] Bora P, Majumdar AS (2017). "Adipose tissue-derived stromal vascular fraction in regenerative medicine: a brief review on biology and translation." Stem Cell Research & Therapy, 8: 145. DOI PubMed
  3. [3] Pak J, Chang JJ, Lee JH, Lee SH (2013). "Safety reporting on implantation of autologous adipose tissue-derived stem cells with platelet-rich plasma into human articular joints." BMC Musculoskeletal Disorders, 14: 337. DOI PubMed
  4. [4] Gentile P, Scioli MG, Bielli A, Orlandi A, Cervelli V (2017). "Concise review: the use of adipose-derived stromal vascular fraction cells and platelet rich plasma in regenerative plastic surgery." Stem Cells, 35: 117-134. DOI PubMed
  5. [5] Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, Granton J, Stewart DJ (2012). "Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials." PLOS ONE, 7: e47559. DOI PubMed
SVF TherapyStromal Vascular FractionStem Cell TherapyAdipose-Derived Stem CellsRegenerative MedicineAutonomic Nerve RegenerationChronic Pain Treatment

This content is provided for informational purposes only and is not a substitute for professional medical advice. If you have symptoms, please consult a qualified physician.

Are you experiencing related symptoms?

Get an accurate diagnosis at OSANG Neurosurgery.